Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images
February 11, 2020 09:00 ET | Royal Philips
February 11, 2020  Randomized controlled trial with up to 3,000 participants at 75 sites to compare outcomes between physiological guidance by iFR data co-registered on the angiogram...
Four-year data from ILLUMENATE Pivotal trial reaffirms safety profile of Philips Stellarex low-dose Drug-Coated Balloon
January 28, 2020 10:00 ET | Royal Philips
January 28, 2020 Mortality rates similar to standard of care through four years with excellent rate of follow-up compliancePhilips Stellarex is the only low-dose Drug-Coated Balloon (DCB) to...
One millionth procedure carried out on Philips Azurion advanced image-guided therapy platform
November 27, 2019 11:00 ET | Royal Philips
November 27, 2019 Industry-leading platform combines clinical excellence and workflow innovation, helping clinicians and hospitals to deliver outstanding patient care ...
Philips announces WE-TRUST multicenter clinical trial to assess impact of ‘Direct to Angio Suite’ workflow on stroke patient outcomes
November 27, 2019 10:00 ET | Royal Philips
November 27, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major clinical trial...
Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients
October 15, 2019 04:00 ET | Royal Philips
October 15, 2019 Stellarex’s unique coating enables a low therapeutic drug dose and has demonstrated a significant treatment effect and high safety profile Amsterdam, the...
Philips and B. Braun launch Onvision needle tip tracking, a breakthrough in real-time ultrasound guidance for regional anesthesia
September 10, 2019 04:00 ET | Royal Philips
September 10, 2019 Integrated point-of-care solution empowers anesthesiologists to perform regional anesthesia procedures, such as peripheral nerve blocks, more safely and efficientlyRegional...
Safety and efficacy of Philips’ Stellarex .035 low-dose drug-coated balloon demonstrated in clinical trials at three years
May 29, 2019 13:00 ET | Royal Philips
May 29, 2019 Stellarex is the only low-dose [1] drug-coated balloon (DCB) to demonstrate a significant treatment effect and high safety profile through 3 years ILLUMENATE Pivotal trial showcases...
Philips launches new IntraSight interventional applications platform to seamlessly integrate intravascular imaging and physiology applications for image-guided procedures  
May 20, 2019 03:59 ET | Royal Philips
May 20, 2019  Integrating best-in-class physiology, imaging and co-registration tools across the interventional lab workflow supports physicians in providing cardiac and peripheral vascular patients...
Philips and Vietnamese Hong Duc General Hospital sign multi-year strategic partnership agreement
April 11, 2019 04:00 ET | Royal Philips
11 April 2019 Philips to provide turnkey hospital solution to newly-built Hong Duc General Hospital II, including the latest medical imaging and healthcare IT solutions as well as design,...
DEFINE PCI study finds treatable cause for significant rates of residual ischemia in coronary stent patients
March 17, 2019 15:30 ET | Royal Philips
March 17, 2019 Nearly one in four patients in the study treated with standard of care percutaneous coronary intervention (PCI) had residual ischemia after coronary stent implantation intended to...